0.70 - 0.75
0.33 - 0.86
15.11M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.24%
Negative revenue growth while 3606.HK stands at 8.52%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-24.76%
Negative gross profit growth while 3606.HK is at 0.26%. Joel Greenblatt would examine cost competitiveness or demand decline.
46.87%
EBIT growth above 1.5x 3606.HK's 12.35%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
46.87%
Operating income growth similar to 3606.HK's 51.81%. Walter Schloss would assume both share comparable operational structures.
-112.51%
Negative net income growth while 3606.HK stands at 48.43%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-112.61%
Negative EPS growth while 3606.HK is at 50.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-114.85%
Negative diluted EPS growth while 3606.HK is at 50.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.05%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-14.84%
Reduced diluted shares while 3606.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-146.12%
Negative OCF growth while 3606.HK is at 79.03%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-96.66%
Negative FCF growth while 3606.HK is at 1099.18%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-33.83%
Negative 10Y revenue/share CAGR while 3606.HK stands at 198.73%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-41.53%
Negative 5Y CAGR while 3606.HK stands at 28.89%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-33.91%
Negative 3Y CAGR while 3606.HK stands at 33.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2026.74%
Negative 10Y OCF/share CAGR while 3606.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-330.94%
Negative 5Y OCF/share CAGR while 3606.HK is at 0.54%. Joel Greenblatt would question the firm’s operational model or cost structure.
-107.08%
Negative 3Y OCF/share CAGR while 3606.HK stands at 49.06%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-102.98%
Negative 10Y net income/share CAGR while 3606.HK is at 533.75%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-105.81%
Negative 5Y net income/share CAGR while 3606.HK is 23.34%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-104.20%
Negative 3Y CAGR while 3606.HK is 2.75%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
631.56%
10Y equity/share CAGR above 1.5x 3606.HK's 372.98%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
14.54%
Below 50% of 3606.HK's 99.06%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.89%
3Y equity/share CAGR at 75-90% of 3606.HK's 23.48%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
-92.85%
Cut dividends over 10 years while 3606.HK stands at 2633.67%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-19.58%
Negative 5Y dividend/share CAGR while 3606.HK stands at 45.87%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-39.20%
Negative near-term dividend growth while 3606.HK invests at 30.53%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-22.12%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
23.92%
We show growth while 3606.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-8.19%
Negative asset growth while 3606.HK invests at 0.01%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.51%
Positive BV/share change while 3606.HK is negative. John Neff sees a clear edge over a competitor losing equity.
38.08%
Debt growth far above 3606.HK's 0.67%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-67.10%
Our R&D shrinks while 3606.HK invests at 8.01%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-20.20%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.